A new drug for patients who have a hard time controlling their asthma could be nearing an FDA review. Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: REGN) and partner Sanofi this morning are touting results this morning from a 1,902-patient Phase 3 study called Liberty Asthma Quest. In it, their injectable antibody drug dupilumab (Dupixent), already approved […]
NYS Entity Status
NYS Filing Date
MARCH 19, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - KOLOVCHEVICH FAMILY LLC
AROUND THE WEB
- Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
By Ben Fidler - Monday Sep 11, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- Young Socialites Conjure the Ghost of Leonard Bernstein at the Dakota
By BEN WIDDICOMBE - Saturday Jun 24, 2017
When Larry Milstein, 22, and his sister Toby, 24, are not hobnobbing on the young socialite circuit, they hold séances in their family’s apartment.
- Man Killed in 9/11 Attacks Is Identified by DNA Testing
By ASHLEY SOUTHALL - Monday Aug 7, 2017
The man, whose name was withheld by officials at his family’s request, was the first Sept. 11 victim to be identified in more than two years.
- Trump’s Tough Talk on North Korea Puts Japan’s Leader in Delicate Spot
By JONATHAN SOBLE - Friday Aug 11, 2017
North Korea’s accelerating military advances — and President Trump’s volatile response — could complicate Japan’s close alliance with the United States.